Tooth loss in Sjögren's syndrome patients compared to age and gender matched controls
- PMID: 30148469
- PMCID: PMC6167098
- DOI: 10.4317/medoral.22545
Tooth loss in Sjögren's syndrome patients compared to age and gender matched controls
Abstract
Background: To analyze the prevalence and location of tooth loss in Sjögren's syndrome (SS) patients and compare them with an age- and gender-matched control group.
Material and methods: Dental charts and x-rays of 108 (SS) patients were retrieved from an academic dental center and special care dentistry department. For each SS patient, an age- and gender-matched non-SS patient was randomly selected. Medication, number of extractions and date and location of extractions were assessed. Differences between SS and non-SS patients were analyzed using Mann-Whitney U tests, Chi-square tests and Fisher's exact tests.
Results: Significantly more SS patients were edentulous compared to the non-SS group (14.8% versus 1.9%, p = 0.001). SS patients had a 61% higher risk to have experienced one or more extractions than control patients. In the SS group, there was a non-significant tendency for more maxillary teeth to have been extracted than mandibular teeth (42:34). In the control group, the number of extractions in the maxilla and mandible were comparable (21:20). When divided into sextants, the number of SS patients with one or more extractions was significantly higher than for non-SS patients for each sextant (p = 0.001 to p = 0.032). The largest difference in the proportion of patients with one or more extractions between the SS and non-SS patients occurred in the upper anterior sextant (3.4 times more frequent).
Conclusions: SS patients are more prone to experience dental extractions compared to patients without SS. It could be speculated that this is related to a decreased salivary secretion.
Conflict of interest statement
Figures
References
-
- Kong L, Ogawa N, McGuff HS, Nakabayashi T, Sakata KM, Masago R. Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol. 1998;88:133–41. - PubMed
-
- Ramos-Casals M, Nardi N, Brito-Zerón P, Aguiló S, Gil V, Delgado G. Atypical Autoantibodies in Patients with Primary Sjögren Syndrome: Clinical Characteristics and Follow-Up of 82 Cases. Semin Arthritis Rheum. 2006;35:312–21. - PubMed
-
- Fox RI. Sjögren's syndrome. Lancet. 2004;366:321–31. - PubMed
-
- Hansen A, Lipsky PE, Dörner T. Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy. Curr Opin Rheumatol. 2005;17:558–65. - PubMed
-
- Haskett S, Ding J, Zhang W, Thai A, Cullen P, Xu S. Identification of Novel CD4+ T Cell Subsets in the Target Tissue of Sjögren's Syndrome and Their Differential Regulation by the Lymphotoxin/LIGHT Signaling Axis. J Immunol. 2016;197:3806–19. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
